Delving into the Latest Updates on Tranzyme with Synapse

概览

关联

1

项与 Tranzyme 相关的药物

TZP-102

靶点

GHSR

作用机制

GHSR激动剂

在研机构-

原研机构

OCERA Therapeutics LLC

在研适应症-

非在研适应症

糖尿病 [+4]

最高研发阶段终止

首次获批国家/地区-

首次获批日期-

13

项与 Tranzyme 相关的临床试验

EUCTR2012-002576-14-PL / Not yet recruitingN/A

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of the Efficacy and Safety of TZP-102 Given Orally Three Times a Day for the Treatment of Symptoms Associated with Diabetic Gastroparesis

开始日期2012-08-23

申办/合作机构

Tranzyme

NCT01664637 / Terminated临床2期

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of the Efficacy and Safety of TZP-102 Given Orally Three Times a Day for the Treatment of Symptoms Associated With Diabetic Gastroparesis

The purpose of this study is to test the safety and effectiveness of 10 mg TZP-102 given prior to meals three times a day compared to placebo (capsule that looks like active study drug but contains no active drug), administered for 12 weeks, in diabetic subjects with symptoms associated with gastroparesis.

开始日期2012-08-01

申办/合作机构

Tranzyme

EUCTR2011-002594-33-BE / Not yet recruiting临床2期

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of the Efficacy and Safety of Once-Daily Administrations of TZP 102 for the Treatment of Symptoms Associated with Diabetic Gastroparesis

开始日期2012-01-30

申办/合作机构

Tranzyme

100 项与 Tranzyme 相关的临床结果

登录后查看更多信息

0 项与 Tranzyme 相关的专利（医药）

登录后查看更多信息

100 项与 Tranzyme 相关的药物交易

登录后查看更多信息

100 项与 Tranzyme 相关的转化医学

登录后查看更多信息